These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36931615)

  • 1. Epithelial-mesenchymal plasticity: Implications for ferroptosis vulnerability and cancer therapy.
    Lee J; Roh JL
    Crit Rev Oncol Hematol; 2023 May; 185():103964. PubMed ID: 36931615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition.
    You JH; Lee J; Roh JL
    Cancer Lett; 2021 Jun; 507():40-54. PubMed ID: 33741422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway.
    Viswanathan VS; Ryan MJ; Dhruv HD; Gill S; Eichhoff OM; Seashore-Ludlow B; Kaffenberger SD; Eaton JK; Shimada K; Aguirre AJ; Viswanathan SR; Chattopadhyay S; Tamayo P; Yang WS; Rees MG; Chen S; Boskovic ZV; Javaid S; Huang C; Wu X; Tseng YY; Roider EM; Gao D; Cleary JM; Wolpin BM; Mesirov JP; Haber DA; Engelman JA; Boehm JS; Kotz JD; Hon CS; Chen Y; Hahn WC; Levesque MP; Doench JG; Berens ME; Shamji AF; Clemons PA; Stockwell BR; Schreiber SL
    Nature; 2017 Jul; 547(7664):453-457. PubMed ID: 28678785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of ferroptosis in head and neck cancer: A novel bridgehead for fighting cancer resilience.
    Lee J; Roh JL
    Cancer Lett; 2022 Oct; 546():215854. PubMed ID: 35973621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcription factor BACH1 at the crossroads of cancer biology: From epithelial-mesenchymal transition to ferroptosis.
    Igarashi K; Nishizawa H; Saiki Y; Matsumoto M
    J Biol Chem; 2021 Sep; 297(3):101032. PubMed ID: 34339740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance.
    Ren Y; Mao X; Xu H; Dang Q; Weng S; Zhang Y; Chen S; Liu S; Ba Y; Zhou Z; Han X; Liu Z; Zhang G
    Cell Mol Life Sci; 2023 Aug; 80(9):263. PubMed ID: 37598126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy.
    Ebrahimi N; Adelian S; Shakerian S; Afshinpour M; Chaleshtori SR; Rostami N; Rezaei-Tazangi F; Beiranvand S; Hamblin MR; Aref AR
    Cytokine Growth Factor Rev; 2022 Apr; 64():33-45. PubMed ID: 35219587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid metabolism alterations and ferroptosis in cancer: Paving the way for solving cancer resistance.
    Lee J; Shin D; Roh JL
    Eur J Pharmacol; 2023 Feb; 941():175497. PubMed ID: 36621602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis As Ultimate Target of Cancer Therapy.
    Motooka Y; Toyokuni S
    Antioxid Redox Signal; 2023 Jul; 39(1-3):206-223. PubMed ID: 35943875
    [No Abstract]   [Full Text] [Related]  

  • 10. Ferroptosis induction via targeting metabolic alterations in head and neck cancer.
    Lee J; Roh JL
    Crit Rev Oncol Hematol; 2023 Jan; 181():103887. PubMed ID: 36442748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience.
    Lee J; Roh JL
    Cancer Lett; 2023 Apr; 559():216119. PubMed ID: 36893895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay.
    Zhang H; Chen N; Ding C; Zhang H; Liu D; Liu S
    Front Oncol; 2024; 14():1344290. PubMed ID: 38469234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis in Cancer Progression.
    Zhang R; Chen J; Wang S; Zhang W; Zheng Q; Cai R
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of GPX4 in ferroptosis and its pharmacological implication.
    Seibt TM; Proneth B; Conrad M
    Free Radic Biol Med; 2019 Mar; 133():144-152. PubMed ID: 30219704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer.
    Liu X; Zhang Y; Wu X; Xu F; Ma H; Wu M; Xia Y
    Front Pharmacol; 2022; 13():909821. PubMed ID: 35847022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persister cell plasticity in tumour drug resistance.
    McDonald PC; Dedhar S
    Semin Cell Dev Biol; 2024 Mar; 156():1-10. PubMed ID: 37977107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer.
    Lee J; You JH; Kim MS; Roh JL
    Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition.
    Wang M; Li S; Wang Y; Cheng H; Su J; Li Q
    Toxicol Appl Pharmacol; 2020 Aug; 401():115110. PubMed ID: 32533954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cashing in on ferroptosis against tumor cells: Usher in the next chapter.
    Valashedi MR; Najafi-Ghalehlou N; Nikoo A; Bamshad C; Tomita K; Kuwahara Y; Sato T; Roushandeh AM; Roudkenar MH
    Life Sci; 2021 Nov; 285():119958. PubMed ID: 34534562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fighting Resilient Cancers with Iron.
    Chen JJ; Galluzzi L
    Trends Cell Biol; 2018 Feb; 28(2):77-78. PubMed ID: 29223642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.